ClassID:

95197

C07D333/58 - CPC Classification

Classification description:

Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems; Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring Radicals substituted by nitrogen atoms

Recent Application in this class:
#1
20250289815
2025-09-18

MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X2 AND RELATED PRODUCTS AND METHODS

#2
20250186391
2025-06-12

ORAL COMPLEMENT FACTOR D INHIBITORS

#3
20240400591
2024-12-05

COMPOUNDS TARGETING MUTANT OF P53

#4
20240166598
2024-05-23

COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THE SAME

#5
20240124410
2024-04-18

SMALL MOLECULES AND THEIR USE AS MALT1 INHIBITORS

#6
20230303567
2023-09-28

Modulators of mas-related G-protein receptor X2 and related products and methods

#7
20230271931
2023-08-31

Carboxylic acid aromatic amides as antagonists of bradykinin B1 receptor

#8
20230159487
2023-05-25

ADVANTAGEOUS BENZOTHIOPHENE COMPOSITIONS FOR MENTAL DISORDERS OR ENHANCEMENT

#9
20230086179
2023-03-23

Carboxylic acid aromatic amides as antagonists of bradykinin B1 receptor

#10
20230061429
2023-03-02

Bicyclic compounds

#11
20230043209
2023-02-09

Carboxylic acid aromatic amides

#12
20230002344
2023-01-05

NOVEL BENZOTHIOPHENE DERIVATIVES AND USE THEREOF FOR STIMULATING MITOCHONDRIAL TURNOVER

#13
20220396581
2022-12-15

COMPOUNDS FOR THE TREATMENT OF PARAMYXOVIRUS VIRAL INFECTIONS

#14
20220340559
2022-10-27

Modulators of Mas-related G-protein receptor X2 and related products and methods

#15
20220298138
2022-09-22

ENZYME INHIBITORS

#16
20220112160
2022-04-14

Small molecule direct inhibitors of KEAP1-NRF2 protein-protein interaction

#17
20210171478
2021-06-10

Polymerizable compound, polymerizable composition and optical film

#18
20210052548
2021-02-25

Mu opioid receptor modulators

#19
20210009552
2021-01-14

Methods for treating protozoan infections

#20
20200290990
2020-09-17

Methods for treating protozoan infections

#21
20200102287
2020-04-02

Methods for treating protozoan infections

#22
20200062738
2020-02-27

ANTI-CANCER STEMNESS DRUGS

#23
20190330178
2019-10-31

Methods for treating protozoan infections

#24
20190315703
2019-10-17

Benzoheterocyclic alkylamine compounds and use thereof

#25
20190229270
2019-07-25

5,12-dihydrotetracene derivative and organic electroluminescence device using the same

#26
20190084941
2019-03-21

Compounds and methods of treating infections

#27
20190076398
2019-03-14

MU opioid receptor modulators

#28
20180362451
2018-12-20

Microbiocidal phenylamidine derivatives

#29
20180207628
2018-07-26

Oxalic amide ligands, and uses thereof in copper-catalyzed coupling reaction of aryl halides

#30
20180022716
2018-01-25

Polymerizable compound and optical isomer

#31
20170360748
2017-12-21

Selective HDAC6 inhibitors and uses thereof

#32
20170291886
2017-10-12

Methods for treating protozoan infections

#33
20170283429
2017-10-05

Compounds for the treatment of paramyxovirus viral infections

#34
20170152268
2017-06-01

Fused heterocyclic ring compounds and method of treating retinal disease using same

#35
20160376251
2016-12-29

Process for the preparation of zileuton

#36
20160333004
2016-11-17

Substituted bicyclic heteroaryl compounds as RXR agonists

#37
20160176806
2016-06-23

Compounds

#38
20160168116
2016-06-16

IRE-1α inhibitors

#39
20160075665
2016-03-17

Compounds and methods of treating infections

#40
20150376204
2015-12-31

Alpha helix mimetic compositions for treating cancer and other CBP/catenin-mediated diseases and conditions

#41
20150303384
2015-10-22

Condensed cyclic compound and organic light-emitting device including the same

#42
20150238498
2015-08-27

Compounds for the treatment of paramoxyvirus viral infections

#43
20150126593
2015-05-07

Compositions and methods for the treatment of asthma and allergy

#44
20140221657
2014-08-07

Alpha helix mimetic compositions for treating cancer and other CBP/catenin-mediated diseases and conditions

#45
20140135320
2014-05-15

Heteroaryl derivatives and uses thereof

#46
20140107247
2014-04-17

Polymerizable compound, polymerizable composition, polymer, and optically anisotropic body

#47
20140080832
2014-03-20

IRE-1α inhibitors

#48
20140077200
2014-03-20

Aromatic amine derivatives and organic electroluminescent device using same

#49
20130331396
2013-12-12

Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase

#50
20130253022
2013-09-26

NOVEL FLUORINATED SULFAMIDES EXHIBITING NEUROPROTECTIVE ACTION AND THEIR METHOD OF USE

#51
20130237571
2013-09-12

Agonists of GPR40

#52
20130072488
2013-03-21

Aralkyl diamine derivatives and uses thereof as antidepressants

#53
20120289471
2012-11-15

NOVEL COMPOUNDS WITH HIGH THERAPEUTIC INDEX

#54
20120270865
2012-10-25

Heterocyclic compound

#55
20120219509
2012-08-30

Guanidine-containing compounds useful as muscarinic receptor antagonists

#56
20120142750
2012-06-07

INDOLEAMINE 2,3-DIOXYGENASE PATHWAYS IN THE GENERATION OF REGULATORY T CELLS

#57
20120059012
2012-03-08

3-(4-aminophenyl)-2-furancarboxylic acid derivative and pharmaceutically acceptable salt thereof

#58
20120053173
2012-03-01

Heterocyclic compound

#59
20120035175
2012-02-09

Novel salts as Anti-Inflammatory, Immunomodulatory and Anti-Proliferatory Agents

#60
20120029034
2012-02-02

Calcium salts of compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents

#61
20120010247
2012-01-12

Bicyclic compound

#62
20120004315
2012-01-05

Selective estrogen receptor modulator

#63
20110319448
2011-12-29

Guanidine-containing compounds useful as muscarinic receptor antagonists

#64
20110269811
2011-11-03

INHIBITORS OF SEMICARBAZIDE-SENSITIVE AMINE OXIDASE (SSAO) AND VAP-1 MEDIATED ADHESION USEFUL FOR TREATMENT AND PREVENTION OF DISEASES

#65
20110263607
2011-10-27

Alpha helix mimetic compositions for treating cancer and other CBP/catenin-mediated diseases and conditions

#66
20110201583
2011-08-18

Guanidine-containing compounds useful as muscarinic receptor antagonists

#67
20110184189
2011-07-28

Process for the preparation of N-(1-benzo[b]thien-2-ylethyl)-N-hydroxyurea

#68
20110172174
2011-07-14

Antibacterial agents

#69
20110098480
2011-04-28

Activating agent for peroxisome proliferator activated receptor

#70
20110065162
2011-03-17

IRE-1α inhibitors

#71
20110053941
2011-03-03

IDO inhibitors

#72
20100324300
2010-12-23

Process for preparing optically active aminopentane derivative, intermediate and process for preparing intermediate

#73
20100324025
2010-12-23

Antibacterial agents

#74
20100317582
2010-12-16

Cyclic hydrocarbon compounds for the treatment of diseases

#75
20100286125
2010-11-11

Hydroxamic acid derivatives of 4-phenyl 4-hydroxy, 4-phenyl 4-alkoxy and 4-phenyl 4-arylalkoxy butyric acid useful as therapeutic agents for treating anthrax poisoning

#76
20100279936
2010-11-04

SUBSTITUTED ACETYLENIC COMPOUNDS USEFUL FOR THE TREATMENT OF DISEASES

#77
20100267780
2010-10-21

Bicyclic aryl and heteroaryl receptor modulators

#78
20100249135
2010-09-30

Sulfonamides and their use as a medicament

#79
20100069489
2010-03-18

L-THREONINE DERIVATIVES OF HIGH THERAPEUTIC INDEX

#80
20100069446
2010-03-18

L-threonine derivatives of high therapeutic index

#81
20100009986
2010-01-14

Substituted heteroaryl derivatives

#82
20100004481
2010-01-07

L-Threonine derivatives of high therapeutic index

#83
20100004297
2010-01-07

Hexafluoroisopropanol derivatives

#84
20100004261
2010-01-07

Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase

#85
20090325930
2009-12-31

Selective estrogen receptor modulator

#86
20090318454
2009-12-24

NOVEL ANTIOXIDANTS AND METHODS OF TREATMENT

#87
20090312328
2009-12-17

Sulfonamide compound or salt thereof

#88
20090298898
2009-12-03

PESTICIDALLY ACTIVE KETONE AND OXIME DERIVATIVES

#89
20090286996
2009-11-19

PROCESS FOR THE PREPARATION OF ZILEUTON

#90
20090264470
2009-10-22

CB1 Antagonists and Inverse Agonists

#91
20090247509
2009-10-01

Heterocyclic substituted carbonyl derivatives and their use as dopamine Dreceptor ligands

#92
20090247506
2009-10-01

Antibacterial agents

#93
20090227627
2009-09-10

6-substituted-thio-2-amino-quinoline derivatives useful as inhibitors of β-secretase (BACE)

#94
20090227585
2009-09-10

SUBSTITUTED N-HETEROCYCLE DERIVATIVES AND METHODS OF THEIR USE

#95
20090203764
2009-08-13

INHIBITORS OF SEMICARBAZIDE-SENSITIVE AMINE OXIDASE (SSAO) AND VAP-1 MEDIATED ADHESION USEFUL FOR TREATMENT AND PREVENTION OF DISEASES

#96
20090186893
2009-07-23

IRE-1α inhibitors

#97
20090176996
2009-07-09

PROCESS FOR THE PREPARATION OF SULFAMIDE DERIVATIVES

#98
20090176865
2009-07-09

Sulfamide derivative useful for the treatment of epilepsy

#99
20090163496
2009-06-25

Antibacterial agents

#100
20090155311
2009-06-18

INDOLEAMINE 2,3-DIOXYGENASE PATHWAYS IN THE GENERATION OF REGULATORY T CELLS

#101
20090136551
2009-05-28

Substituted Dicyanoalkanes For Combating Animal Pests

#102
20090131400
2009-05-21

Immunosuppressant compounds and compositions

#103
20090124813
2009-05-14

Process for preparing optically active aminopentane derivative, intermediate and process for preparing intermediate

#104
20090118453
2009-05-07

Metal complexes

#105
20090099236
2009-04-16

3-amino-1-arylpropyl indoles and AZA-substituted indoles and uses thereof

#106
20090082372
2009-03-26

Arylmethylene Substituted N-Acyl-Beta-Amino Alcohols

#107
20090069335
2009-03-12

Guanidine-containing compounds useful as muscarinic receptor antagonists

#108
20090054235
2009-02-26

Benzoheterocyclylethylbenzamide derivatives

#109
20090048224
2009-02-19

COMPOUNDS AND METHODS OF USE

#110
20090042929
2009-02-12

11-Beta-Hydroxysteroid Dehydrogenase Inhibitors

#111
20090036501
2009-02-05

2-cyclopenten-1-one oxime derivatives inhibiting production of TNF-α

#112
20080300260
2008-12-04

Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mGlu2 receptor)

#113
20080269221
2008-10-30

Antibacterial agents

#114
20080249102
2008-10-09

HIV protease inhibitors

#115
20080234272
2008-09-25

Piperazines as antimalarial agents

#116
20080200525
2008-08-21

Pesticidally active ketone and oxime derivatives

#117
20080200461
2008-08-21

MODULATORS OF ACETYL-COENZYME A CARBOXYLASE AND METHODS OF USE THEREOF

#118
20080167347
2008-07-10

Ctgf Expression Inhibitor

#119
20080153826
2008-06-26

Substituted aryl cycloalkanoyl derivatives and methods of their use

#120
20080132567
2008-06-05

Alpha-aminoamide derivatives useful in the treatment of lower urinary tract disorders

#121
20080132459
2008-06-05

Inhibitors of histone deacetylase

#122
20080108839
2008-05-08

Aromatic amine derivatives and organic electroluminescent device using same

#123
20080108832
2008-05-08

AROMATIC AMINE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME

#124
20080106190
2008-05-08

AROMATIC AMINE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME

#125
20080096937
2008-04-24

Novel hexafluoroisopropanol derivatives

#126
20080064730
2008-03-13

Azine Compounds for Combating Animal Pests

#127
20080027087
2008-01-31

CB1 antagonists and inverse agonists

#128
20070293548
2007-12-20

Inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and VAP-1 mediated adhesion useful for treatment and prevention of diseases

#129
20070244197
2007-10-18

Antibacterial agents

#130
20070244185
2007-10-18

Crystal form and pharmaceutical compositions of (+)-R-zileuton

#131
20070232685
2007-10-04

CRYSTALLINE FORMS OF N-(BENZO[B]THIEN-3-YLMETHYL)-SULFAMIDE

#132
20070232602
2007-10-04

Thiophene derivatives, their manufacture and use as pharmaceutical agents

#133
20070219246
2007-09-20

Dihydrobenzothiophenes

#134
20070213377
2007-09-13

Hexafluoroisopropanol derivatives

#135
20070197577
2007-08-23

Inhibitors of anthrax lethal factor

#136
20070185113
2007-08-09

Heteroaryl and benzyl amide compounds

#137
20070161641
2007-07-12

Heterocyclic substituted carbonyl derivatives and their use as dopamine D receptor ligands

#138
20070142351
2007-06-21

Heterocyclic amide derivatives and their use as dopamine D3 receptor ligands

#139
20070142333
2007-06-21

CYCLOALKYL INHIBITORS OF POTASSIUM CHANNEL FUNCTION

#140
20070123527
2007-05-31

3-amino-1-arylpropyl indoles and aza-substituted indoles and uses thereof

#141
20070099876
2007-05-03

Target directed chemotherapy of tumours of the sexual organs

#142
20070068450
2007-03-29

Nitrogen semiconductor compound and device fabricated using the same

#143
20070060587
2007-03-15

Indane derivates as muscarinic receptor agonists

#144
20070043077
2007-02-22

Aryl-carbaldehyde oxime derivatives and their use as estrogenic agents

#145
20060293336
2006-12-28

C-linked cyclic antagonists of P2Yreceptor useful in the treatment of thrombotic conditions

#146
20060287244
2006-12-21

L-Threonine derivatives of high therapeutic index

#147
20060276528
2006-12-07

Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents

#148
20060270856
2006-11-30

Process for preparation of sulfamide derivatives

#149
20060258723
2006-11-16

Substituted Heteroaryl- and Phenylsulfamoyl Compounds

#150
20060241259
2006-10-26

Oxime ester photoinitiators with heteroaromatic groups

#151
20060241017
2006-10-26

Compounds with high therapeutic index

#152
20060199856
2006-09-07

Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents

#153
20060189646
2006-08-24

Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof

#154
20060183791
2006-08-17

Substituted p-diaminobenzene derivatives

#155
20060173184
2006-08-03

Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase

#156
20060154988
2006-07-13

Antibacterial agents

#157
20060154925
2006-07-13

Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof

#158
20060128670
2006-06-15

Pesticidally active ketone and oxime derivatives

#159
20060116364
2006-06-01

Selective estrogen receptor modulator

#160
20060069098
2006-03-30

Bicyclic compound

#161
20060063760
2006-03-23

Hydroxamic acids useful in the treatment of hyper-proliferative disorders

#162
20060047001
2006-03-02

Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents

#163
20060030599
2006-02-09

Sulphonamide derivatives

#164
20060014830
2006-01-19

Arylalkylcarbamate derivatives and production thereof

#165
20060014822
2006-01-19

1,2,4-Triaminobenzene derivatives useful for treating disorders of the central nervous system

#166
20060014797
2006-01-19

Sleep inducing compounds and methods relating thereto

#167
20060004068
2006-01-05

Hexafluoroisopropanol derivatives

#168
20050245543
2005-11-03

Histamine-3 receptor antagonists

#169
20050234106
2005-10-20

Cycloalkyl inhibitors of potassium channel function

#170
20050234058
2005-10-20

Secondary amino-and cycloamino-cycloalkanol derivatives and methods of their use

#171
20050228015
2005-10-13

Substituted heteroaryl- and phenylsulfamoyl compounds

#172
20050192283
2005-09-01

Fused-aryl and heteroaryl derivatives and methods of their use

#173
20050187251
2005-08-25

Substituted N-heterocycle derivatives and methods of their use

#174
20050171115
2005-08-04

Alkanol and cycloalkanol-amine derivatives and methods of their use

#175
20050143579
2005-06-30

Substituted aryl cycloalkanol derivatives and methods of their use

#176
20050124682
2005-06-09

Substituted cyclic compounds

#177
20050124654
2005-06-09

Compounds and methods of use

#178
20050107389
2005-05-19

Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands

#179
20050059729
2005-03-17

Substituted cyclic compounds

#180
20050043370
2005-02-24

HIV integrase inhibitors

#181
20050014725
2005-01-20

Immunosuppressant compounds and compositions

#182
20050009907
2005-01-13

Aryl-carbaldehyde oxime derivatives and their use as estrogenic agents